$$ IVOICE INC $$
Seite 2 von 2 Neuester Beitrag: 01.04.08 17:23 | ||||
| Eröffnet am: | 26.10.06 12:19 | von: carpediem7 | Anzahl Beiträge: | 42 |
| Neuester Beitrag: | 01.04.08 17:23 | von: 0815ax | Leser gesamt: | 6.276 |
| Forum: | Hot-Stocks | Leser heute: | 7 | |
| Bewertet mit: |  | |||
| Seite: < 1 | > | ||||
Rebound im Anmarsch ??? -wieder gen 0.01 ???
Meinungen !?
ax
21:35 08.11.07
Fifth Spin-Off and Fifth Stock Dividend to the Shareholders
MATAWAN, N.J.--(BUSINESS WIRE)--iVoice, Inc. (OTC Bulletin Board: IVOI), announced today the record date
of November 14, 2007 for the pending spin-off in the form of a special
dividend of its wholly owned subsidiary, Thomas Pharmaceuticals Ltd. (Thomas
Pharmaceuticals).
Each iVoice shareholder of record as of November 14 2007 will receive
shares of Thomas Pharmaceuticals. In order to receive shares in
Thomas Pharmaceuticals, you must own shares of iVoice, Inc. on the
record date of November 14, 2007. It is anticipated that the
distribution in the form of a special dividend of Thomas Pharmaceuticals
shares will occur sometime in November 2007. Following the distribution,
Thomas Pharmaceuticals plans to have its shares traded on the NASD OTC
Bulletin Board. Each holder of iVoice Class A Common Stock, except for
certain affiliates, will receive one share of Thomas Pharmaceuticals,
Ltd. Class A Common Stock for each share of iVoice Class A Common Stock
held.
The Company revised the record date for the distribution of the Thomas
Pharmaceuticals spin-off to November 14, 2007 to permit the Company to
register additional shares with the Securities and Exchange Commission
to reflect the recent increase in the number of outstanding shares of
iVoice as a result of a conversion by a holder of an outstanding
convertible debenture to Class A Common Stock of iVoice.
About iVoice, Inc:
iVoice has determined that the best way to create shareholder value,
separate and apart from the operating performance of iVoice, is to
implement new business opportunities by distributing shares of spin-offs
to the Company's shareholders. The common stock distributions are part
of a broader strategy relating to the transition of iVoice into a
company focused on the development and licensing of proprietary
technologies. We also continue to search for potential merger candidates
with or without compatible technology and products, which management
feels may make financing more appealing to potential investors.
Certain information included in this press release, may contain
forward-looking statements about our current and expected performance
trends, growth plans, business goals and other matters. These statements
may be contained in our filings with the Securities and Exchange
Commission, in our press releases, in other written communications, and
in oral statements made by or with the approval of one of our authorized
officers. Information set forth in this press release contains various
"forward-looking statements" within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange Act of
1934. The Private Securities Litigation Reform Act of 1995 (the "Act")
provides certain "safe harbor" provisions for forward-looking
statements. The reader is cautioned that such forward-looking statements
are based on information available at the time and/or management's good
faith belief with respect to future events, and are subject to risks and
uncertainties that could cause actual performance or results to differ
materially from those expressed in the statements. Forward-looking
statements speak only as of the date the statement was made. We assume
no obligation to update forward-looking information to reflect actual
results, changes in assumptions or changes in other factors affecting
forward-looking information. Forward-looking statements are typically
identified by the use of terms such as "anticipate," "believe," "could,"
"estimate," "expect," "intend," "may," "might," "plan," "predict,"
"project," "should," "will," and similar words, although some
forward-looking statements are expressed differently. Although we
believe that the expectations reflected in such forward-looking
statements are reasonable, we can give no assurance that such
expectations will prove to be correct.
For more information on iVoice, please visit http://www.ivoice.com
- für jede Ivoice-Aktie, die man am Stichtag (dieser ist der 14.11.07) in seinem Depot liegen hat, bekommt man auch eine Dividende in der Form einer Thomas Pharmaceuticals-Aktie (im Verlauf des Novembers)! Diese werden dann gehandelt an der NASDOTC:BB.
++++++++++++++++++++++++++++++++++++++++++++++++++
Each iVoice shareholder of record as of November 14 2007 will receive
shares of Thomas Pharmaceuticals.
It is anticipated that the
distribution in the form of a special dividend of Thomas Pharmaceuticals
shares will occur sometime in November 2007.
Each holder of iVoice Class A Common Stock, except for
certain affiliates, will receive one share of Thomas Pharmaceuticals.
Thomas Pharmaceuticals plans to have its shares traded on the NASD OTC
Bulletin Board.
++++++++++++++++++++++++++++++++++++++++++++++++++
15.11.2007 12:13
iVoice, Inc. Announces Completion of Spin-off of Thomas Pharmaceuticals Ltd.
iVoice, (Nachrichten) Inc., (OTC Bulletin Board: IVOI), today announced that it has completed the spin-off of its wholly-owned subsidiary Thomas Pharmaceuticals Ltd. iVoice will distribute through a special dividend the Class A Common Stock shares of the subsidiary to its shareholders, and thereafter, the entity will operate as independent public company.
Each iVoice shareholder of record on November 14 2007 will receive one (1) share of Thomas Pharmaceuticals for every one (1) share of iVoice, Inc. that they own as of the record date. In order to receive shares in Thomas Pharmaceuticals, you must have owned shares of iVoice, Inc. on the record date of, November 14 2007. iVoice shareholders can expect to receive the Thomas Pharmaceuticals Ltd. shares in the next few weeks.
Thomas Pharmaceuticals Ltd. will file the appropriate paperwork with the NASD to begin trading on the NASD Over the Counter Bulletin Board. The companies expect that the shares will commence trading sometime in the next several months.
Registration statements relating to the securities of Thomas Pharmaceuticals Ltd. have been filed with and declared effective by the Securities and Exchange Commission. This communication shall not constitute an offer to sell or the solicitation of an offer to buy nor there any sale of these securities in any state in which such offer solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.
About iVoice, Inc:
iVoice has determined that the best way to create shareholder value, separate and apart from the operating performance of iVoice, is to implement new business opportunities by distributing shares of spin-offs to the Company's shareholders. The common stock distributions are part of a broader strategy relating to the transition of iVoice into a company focused on the development and licensing of proprietary technologies. We also continue to search for potential merger candidates with or without compatible technology and products, which management feels may make financing more appealing to potential investors.
Certain information included in this press release, may contain forward-looking statements about our current and expected performance trends, growth plans, business goals and other matters. These statements may be contained in our filings with the Securities and Exchange Commission, in our press releases, in other written communications, and in oral statements made by or with the approval of one of our authorized officers. Information set forth in this press release contains various "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The Private Securities Litigation Reform Act of 1995 (the "Act") provides certain "safe harbor" provisions for forward-looking statements. The reader is cautioned that such forward-looking statements are based on information available at the time and/or management's good faith belief with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the statements. Forward-looking statements speak only as of the date the statement was made. We assume no obligation to update forward-looking information to reflect actual results, changes in assumptions or changes in other factors affecting forward-looking information. Forward-looking statements are typically identified by the use of terms such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "might," "plan," "predict," "project," "should," "will," and similar words, although some forward-looking statements are expressed differently. Although we believe that the expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such expectations will prove to be correct.
For more information on iVoice, please visit http://www.ivoice.com
30.11.2007 16:34
iVoice, Inc. Announces Information Regarding Spin-Off of Thomas Pharmaceuticals Ltd. to Shareholders and Shares to be Distributed
iVoice, (Nachrichten) Inc. (OTC Bulletin Board: IVOI) has released information in response to numerous inquiries regarding the distribution of the shares of Thomas Pharmaceuticals Ltd. to shareholders.
The shares have been distributed to the shareholders of record and should be in your account shortly.
Each iVoice shareholder of record on November 14 2007 will receive one (1) share of Thomas Pharmaceuticals for every one (1) share of iVoice, Inc. that they own as of the record date. In order to receive shares in Thomas Pharmaceuticals, you must have owned shares of iVoice, Inc. on the record date of, November 14 2007. iVoice shareholders can expect to receive the Thomas Pharmaceuticals Ltd. shares in the next few weeks.
A prospective market maker of Thomas Pharmaceuticals Ltd. common stock has filed the appropriate paperwork with the NASD to commence trading of Thomas Pharmaceuticals on the NASD Over the Counter Bulletin Board. The Company anticipates that the shares will commence trading sometime in the next several months.
Registration statements relating to the securities of Thomas Pharmaceuticals Ltd. have been filed with and declared effective by the Securities and Exchange Commission. This communication shall not constitute an offer to sell or the solicitation of an offer to buy nor any sale of these securities in any state in which such offer solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.
About iVoice, Inc:
iVoice has determined that the best way to create shareholder value, separate and apart from the operating performance of iVoice, is to implement new business opportunities by distributing shares of spin-offs to the Company's shareholders. The common stock distributions are part of a broader strategy relating to the transition of iVoice into a company focused on the development and licensing of proprietary technologies. We also continue to search for potential merger candidates with or without compatible technology and products, which management feels may make financing more appealing to potential investors.
Certain information included in this press release, may contain forward-looking statements about our current and expected performance trends, growth plans, business goals and other matters. These statements may be contained in our filings with the Securities and Exchange Commission, in our press releases, in other written communications, and in oral statements made by or with the approval of one of our authorized officers. Information set forth in this press release contains various "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The Private Securities Litigation Reform Act of 1995 (the "Act") provides certain "safe harbor" provisions for forward-looking statements. The reader is cautioned that such forward-looking statements are based on information available at the time and/or management's good faith belief with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the statements. Forward-looking statements speak only as of the date the statement was made. We assume no obligation to update forward-looking information to reflect actual results, changes in assumptions or changes in other factors affecting forward-looking information. Forward-looking statements are typically identified by the use of terms such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "might," "plan," "predict," "project," "should," "will," and similar words, although some forward-looking statements are expressed differently. Although we believe that the expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such expectations will prove to be correct.
For more information on iVoice, please visit http://www.ivoice.com.
Immer wieder gerne
06.12.2007 12:13
iVoice Receives Patent Award for ''Methodology for Talking Consumer Products with Voice Instructions via Wireless Technology''
iVoice, (Nachrichten) Inc. (OTC Bulletin Board: IVOI) - iVoice, Inc. (OTC Bulletin Board: IVOI), announced today it has received United States Patent, 7,305,344 for a patent “Methodology for Talking Consumer Products with Voice Instructions via Wireless Technology“.
This invention enables users of new products to activate the speaking package of a new product, so there is no need to read instructions. For example, it provides for hands free, eyes free, instructions while assembling new products, such as bicycle, furniture, camera or other products.
To a person with low vision or a physical disability, talking instruction products can mean independence. Talking products offer independence to people with limited use of their hands or to people whose vision is limited. The result is greater satisfaction with their ability to control their own environment and less dependence on caregivers to attend to these common tasks.
“The grant of this patent is centrally important to iVoice, Inc. not only to preserve its technology but also to leverage offensively in the marketplace,“ said Mr. Mahoney. The patent award will make a significant milestone in product development for the iVoice technical staff. iVoice's commitment to innovation technology continues to help customers meet their client requirements. We believe that our intellectual property and our technology provide iVoice with a superior suite of application offerings.
About iVoice, Inc:
iVoice has determined that the best way to create shareholder value, separate and apart from the operating performance of iVoice, is to spin-off previous wholly owned subsidiaries of iVoice to its shareholders by distributing shares of these subsidiaries in the form of a special dividend. To date, iVoice has successfully completed the spin-off of Trey Resources, Inc. (OTCBB: TYRIA), iVoice Technology, Inc. (OTCBB: IVOT), SpeechSwitch, Inc. (OTCBB: SSWC) and Thomas Pharmaceuticals, Ltd. The common stock distributions are part of a broader strategy relating to the transition of iVoice into a company focused on the development and licensing of proprietary technologies. We also continue to search for potential merger candidates with or without compatible technology and products, which management feels may make financing more appealing to potential investors.
Certain information included in this press release, may contain forward-looking statements about our current and expected performance trends, growth plans, business goals and other matters. These statements may be contained in our filings with the Securities and Exchange Commission, in our press releases, in other written communications, and in oral statements made by or with the approval of one of our authorized officers. Information set forth in this press release contains various "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The Private Securities Litigation Reform Act of 1995 (the "Act") provides certain "safe harbor" provisions for forward-looking statements. The reader is cautioned that such forward-looking statements are based on information available at the time and/or management's good faith belief with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the statements. Forward-looking statements speak only as of the date the statement was made. We assume no obligation to update forward-looking information to reflect actual results, changes in assumptions or changes in other factors affecting forward-looking information. Forward-looking statements are typically identified by the use of terms such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "might," "plan," "predict," "project," "should," "will," and similar words, although some forward-looking statements are expressed differently. Although we believe that the expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such expectations will prove to be correct.
For more information on iVoice, please visit http://www.ivoice.com.
http://www.finanznachrichten.de/...ichten-2008-01/artikel-9821610.asp
08.01.2008 12:22
iVoice Enters into Technology Transfer Agreement with GlynnTech
iVoice, (News) Inc. (OTC Bulletin Board: IVOI), announced today that it has entered into a Technology Transfer Agreement With GlynnTech to market its recently issued patent, “Methodology for Talking Consumer Products with Voice Instructions via Wireless Technology.“
Jerry Mahoney, CEO of iVoice, Inc. said, “This invention enables users of new products to activate the speaking package of a new product, so there is no need to read instructions. For example, it provides for hands free, eyes free instructions while assembling new products, such as a bicycle, furniture, camera or other products.“
iVoice, Inc., with GlynnTech's, Inc. assistance will develop a DVD of the patent's capabilities, GlynnTech, Inc., will assist in the preparation of the script, production and editing of the product DVD and receive a credits on the DVD. GlynnTech, Inc. will be obligated to solicit licensing opportunities and or acquisition of the patent.
Ken Glynn, president of GlynnTech Inc., has been involved in licensing of a variety of technologies for more than thirty years Besides representing such diverse, successful products as the SuperSoaker® Watergun, and the RotoWrench®, Glynn has successfully licensed or sold more than thirty-four patents in the field of containers and packaging. He stated that this technology could eventually become a widespread method of using many consumer products.
About iVoice, Inc:
iVoice has determined that the best way to create shareholder value, separate and apart from the operating performance of iVoice, is to spin-off previous wholly owned subsidiaries of iVoice to its shareholders by distributing shares of these subsidiaries in the form of a special dividend. To date, iVoice has successfully completed the spin-off of Trey Resources, Inc. (OTCBB: TYRIA), iVoice Technology, Inc. (OTCBB: IVOT), SpeechSwitch, Inc. (OTCBB: SSWC) and Thomas Pharmaceuticals, Ltd. The common stock distributions are part of a broader strategy relating to the transition of iVoice into a company focused on the development and licensing of proprietary technologies. We also continue to search for potential merger candidates with or without compatible technology and products, which management feels may make financing more appealing to potential investors.
Certain information included in this press release, may contain forward-looking statements about our current and expected performance trends, growth plans, business goals and other matters. These statements may be contained in our filings with the Securities and Exchange Commission, in our press releases, in other written communications, and in oral statements made by or with the approval of one of our authorized officers. Information set forth in this press release contains various "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. The Private Securities Litigation Reform Act of 1995 (the "Act") provides certain "safe harbor" provisions for forward-looking statements. The reader is cautioned that such forward-looking statements are based on information available at the time and/or management's good faith belief with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in the statements. Forward-looking statements speak only as of the date the statement was made. We assume no obligation to update forward-looking information to reflect actual results, changes in assumptions or changes in other factors affecting forward-looking information. Forward-looking statements are typically identified by the use of terms such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "might," "plan," "predict," "project," "should," "will," and similar words, although some forward-looking statements are expressed differently. Although we believe that the expectations reflected in such forward-looking statements are reasonable, we can give no assurance that such expectations will prove to be correct.
For more information on iVoice, please visit http://www.ivoice.com.
Was NEWS doch so ausmachen...
ax
gestrige Tagesspitze bei 0,0019$
...spekulativ könnten News oder gute Umsatzzahlen der Auslöser dieser vermehrten Kaufaktivitäten sein...
ax
SEC EDGAR Filing Information Form 8-K -- Current report
SECTION 1 - REGISTRANT'S BUSINESS AND OPERATIONS
ITEM 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT.
On February 22, 2008, iVoice, Inc. (the "Company") entered into an Amendment
Agreement dated February 21, 2008 with YA Global Investments L.P. ("YA Global")
whereby the terms of a Secured Convertible Debenture dated May 26, 2006 with an
original principal amount of $1,250,000 were amended whereby:
a. The term of this secured convertible debenture was extended from the
original expiration date of May 25, 2008 to May 25, 2010.
b. The interest rate was revised from 7.5% to 15% effective March 1,
2008.
c. The conversion price was revised from ninety percent (90%) to seventy
percent (70%) of the lowest Closing Bid Price of the Common Stock
during the thirty (30) days trading days immediately preceding the
Conversion Date, as quoted by Bloomberg, LP.
The Company also agreed to fully repay a second Secured Convertible Debenture
held by YA Global originally dated May 11, 2006 on its expiration date of May
11, 2008 with a current principal amount equal to $4,986,510.
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.
(d) Exhibits
10.1 Amendment Agreement dated February 21, 2008 by and between
iVoice, Inc. and YA Global Investments LP.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
IVOICE, INC,
Date: February 26, 2008 By: /s/ Jerome R. Mahoney
---------------------
Jerome R. Mahoney
President, Secretary and Chief
Executive Officer
INDEX OF EXHIBITS
10.1 Amendment Agreement dated February 21, 2008 by and between iVoice,
Inc. and YA Global Investments LP.
